Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptonemal complex protein 2 (SYCP2) is an essential meiosis-specific structural protein that forms a critical component of the axial/lateral elements of the synaptonemal complex—a scaffold that physically links homologous chromosomes during prophase I of meiosis[1][2][4]. SYCP2 is required for correct assembly and function of the synaptonemal complex, ensuring homologous chromosome synapsis, pairing, and recombination[1][2][3][4]. Through direct interactions with other synaptonemal complex proteins (e.g., SYCP1, SYCP3), SYCP2 is necessary for the integration and organization of chromatin during gametogenesis. Disruption of SYCP2, whether by loss-of-function mutations or aberrant regulation, impairs complex assembly and leads to defective spermatogenesis, resulting in male infertility. Ectopic expression of SYCP2 has also been detected in certain premalignant tissues, implicating its dysregulation in genomic instability and potentially linking it to some cancers[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptonemal complex protein 2 (SYCP2).